decamethonium has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
decamethonium: RN given refers to parent cpd
decamethonium : A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ORNDAHL, G | 1 |
| STENBERG, K | 1 |
1 other study available for decamethonium and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Myotonic human musculature: stimulation with depolarizing agents. Mechanical registration of the effects of succinyldicholine, succinylmonocholine and decamethonium.
Topics: Amyotrophic Lateral Sclerosis; Decamethonium Compounds; Humans; Muscular Atrophy; Muscular Dystrophi | 1962 |